Keyphrases
Turkey
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
76%
COVID-19
73%
Breast Cancer Patients
72%
Helicobacter Pylori (H. pylori)
71%
Chronic Hepatitis B
54%
Healthy Controls
53%
Oncology
51%
Behet's Disease
49%
Hepatitis B Virus
49%
Overall Survival
48%
Oxidative Stress
47%
Breast Cancer
44%
Next-generation Sequencing
44%
Blood Samples
41%
Chemotherapy
40%
Cancer Patients
40%
Hepatitis B Virus Infection
39%
Total Antioxidant Capacity
38%
Chronic Hepatitis B Patients
38%
DNA Damage
38%
Oxidative Stress Markers
37%
Serum Leptin
36%
Oxidative Status
36%
Nonalcoholic Steatohepatitis
35%
Cirrhosis
34%
Confidence Interval
34%
Helicobacter Pylori Eradication
34%
Hepatitis B Surface Antigen (HBsAg)
33%
Adult Patients
32%
Tumor
31%
Patients with Breast Cancer
31%
Disease-free Survival
31%
Entecavir
31%
In Cancer
30%
Helicobacter Pylori Infection
30%
Hepatitis C Virus Infection
29%
Paraoxonase-1 Activity
29%
Leptin Levels
29%
MEFV Gene
29%
Disease Progression
28%
CoronaVac
28%
Multivariate Analysis
28%
Hepatitis B
28%
Risk Factors
28%
Ulcer
25%
Inflammation
25%
Colorectal Cancer
25%
Hemodialysis
25%
Metastatic Breast Cancer
24%
Ulcerative Colitis
24%
Anemia
24%
Autoinflammatory Diseases
24%
Progression-free Survival
24%
Real-life Data
24%
Acute Kidney Injury
23%
Hematology
23%
Survival Outcomes
23%
Chronic Hepatitis
23%
Liver
23%
High Dose
22%
Pathogenic Variants
22%
MUTYH
22%
Hepatitis B Infection
22%
Genome-wide Association Study
22%
Na-K
21%
Real-world Experience
21%
Trastuzumab
21%
Granulocyte Colony-stimulating Factor (G-CSF)
21%
Phase II Trial
21%
Total Peroxides
21%
Quantitative PCR
21%
Cirrhotic Patients
20%
Polymorphism
20%
Total Oxidant Status
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Invasive Pulmonary Aspergillosis
19%
Alveolar Echinococcosis
19%
Hemodialysis Patients
19%
Etoposide
19%
Case-controlled Study
19%
Ischemia-reperfusion Injury
19%
Education Group
19%
Hepatitis C
19%
Arylesterase Activity
19%
Hepatic Veno-occlusive Disease
19%
Polyps
19%
Sinusoidal Obstruction Syndrome
19%
Acute Leukemia
19%
Lymphocyte DNA Damage
19%
Toll-like
19%
Chronic Myeloid Leukemia
19%
Bone Mineral Density
19%
HER2-positive Gastric Cancer
19%
Chronic Hepatitis C
19%
Hormone Receptor-positive
19%
Patient Assessment
19%
Tenofovir
19%
Hepatocellular Carcinoma Risk
19%
Inflammatory Index
19%
Medicine and Dentistry
Breast Cancer
84%
Hepatitis B Virus
58%
Overall Survival
55%
COVID-19
52%
Nonalcoholic Fatty Liver
49%
Neoplasm
49%
Hepatitis B
46%
Disease Free Survival
41%
Lymphocyte
38%
Prevalence
33%
Echinococcosis
31%
Liver Cirrhosis
29%
Chronic Hepatitis B
27%
Platelet
27%
Oxidative Stress
25%
Lung
24%
Biopsy Technique
24%
Anemia
23%
BRCA1
23%
Hepatocellular Carcinoma
23%
Prognostic Factor
23%
Disease Exacerbation
22%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Mean Platelet Volume
21%
Antioxidant
20%
Polymerase Chain Reaction
20%
Colorectal Carcinoma
20%
Hepatic Veno-Occlusive Disease
19%
Acute Leukemia
19%
Leptin
19%
Liver Venoocclusive Disease
19%
Polyp
19%
Hematopoietic Stem Cell Transplantation
19%
DNA Damage
19%
Chronic Hepatitis C
19%
Helicobacter Pylori
19%
Familial Cancer
19%
Cyclin-Dependent Kinase
19%
Intention-to-Treat Analysis
19%
Stomach Mucosa
17%
Progression Free Survival
16%
Hazard Ratio
16%
Hypochromic Anemia
15%
Liver Fibrosis
15%
Leukemia
15%
Metastatic Breast Cancer
15%
Child-Pugh Score
14%
Polysplenia
14%
Multiple Myeloma
14%
Gastrectomy
14%
Tumor Localization
14%
Computer Assisted Tomography
14%
Metastatic Carcinoma
14%
Neutrophil
14%
Vein Occlusion
14%
Tumor Necrosis Factor
14%
Fibrosis
14%
Finger
13%
Laparotomy
13%
Congenital Malformation
13%
Patient with Ulcerative Colitis
13%
Clinical Feature
13%
High Risk Population
12%
Combination Therapy
12%
Odds Ratio
12%
Colon
12%
Early Diagnosis
12%
Primary Tumor
11%
Portal Hypertension
11%
Metabolic Syndrome
11%
Lamivudine
11%
Trastuzumab
11%
Arm
11%
Hematopoietic Cell
11%
Budd-Chiari Syndrome
11%
Endoscopy
11%
Chronic Hepatitis
11%
Wound Healing
11%
Alanine Aminotransferase
11%
Metastasectomy
11%
Smoking Habit
10%
Gene Mutation
10%
Cisplatin
10%
Factor V Leiden
10%
Index Case
10%
Entecavir
10%
Heterotopic
9%
Mitomycin
9%
Polycythemia vera
9%
Laryngopharyngeal Reflux
9%
Mastocytosis
9%
Puncture
9%
Base Excision Repair
9%
Idiopathic Thrombocytopenic Purpura
9%
Gastrointestinal Cancer
9%
Stem Cell Mobilization
9%
Brusatol
9%
Renal Biopsy
9%
Human Immunodeficiency Virus
9%
Thrombotic Thrombocytopenic Purpura
9%